Profil
Alan Naylor founded Pathios Therapeutics Ltd. in 2017, where he is working as Head-Drug Discovery from 2017.
Dr. Naylor also currently works at Brandon Capital Partners Pty Ltd., as Advisor from 2015.
Dr. Naylor received his graduate degree from the University of Liverpool Management School.
Postes actifs de Alan Naylor
| Sociétés | Poste | Début |
|---|---|---|
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Fondateur | 01/01/2017 |
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Consultant / Advisor | 01/01/2015 |
Formation de Alan Naylor
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Brandon Capital Partners Pty Ltd.
Brandon Capital Partners Pty Ltd. Investment ManagersFinance Brandon Capital Partners invests in companies located in the Australia and New Zealand. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements. | Finance |
Pathios Therapeutics Ltd.
Pathios Therapeutics Ltd. BiotechnologyHealth Technology Engages in discovering and developing novel small molecule drugs | Health Technology |
University of Liverpool Management School
University of Liverpool Management School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
















